Skip to main content
. 2012 Oct 27;12:498. doi: 10.1186/1471-2407-12-498

Table 4.

Fit of the model to the data for the 27 blocks with grouped data

Block: studya Measureb Rangec FEV1%P Diffd RR (95%CI) Fitted RR Cases observede Cases fitted
1: BEATY
FEV1%P
>80
(95.33)
1.00
1.00
14.30
14.30
β (SE) =
−0.028 (0.034)
≤80
29.77
0.43 (0.06-3.20)
0.43
1.03
1.03
2: CALABR
FEV1%P
90+
(104.94)
1.00
1.00
24.20
25.71
β (SE) =
0.024 (0.008)
70 to <90
23.90
2.29 (1.24-4.23)
1.76
17.09
13.98
χ2 (df) =
1.04 (1)
<70
49.60
2.90 (1.34-6.27)
3.25
8.50
10.11
3: CARETf
FEV1%P
80+
(100.75)
1.00
1.00
35.35
34.69
β (SE) =
0.022 (0.007)
70 to <80
24.89
1.54 (0.80-2.63)
1.74
14.59
16.20
χ2 (df) =
0.22 (2)
60 to <70
34.92
2.25 (1.20-4.19)
2.18
12.39
11.77
 
 
<60
49.07
3.08 (1.42-6.69)
2.99
6.92
6.59
4: CARETg
FEV1%P
80+
(91.97)
1.00
1.00
16.66
15.78
β (SE) =
0.012 (0.006)
70 to <80
16.94
1.05 (0.56-1.96)
1.22
19.07
20.99
χ2 (df) =
0.25 (2)
60 to <70
26.77
1.33 (0.74-2.42)
1.36
24.04
23.27
 
 
<60
47.77
1.66 (0.95-2.89)
1.74
34.62
34.35
5: CARTA
FEV1/FVC
90+
(99.82)
1.00
1.00
3.72
7.84
β (SE) =
0.072 (0.049)
80 to <90
−0.99
3.87 (1.12-15.05)
0.93
5.83
2.95
χ2 (df) =
5.25 (1), p<0.05
<80
9.64
5.18 (1.56-19.66)
2.00
6.66
5.42
6: FINKEL
FEV1%P
100+
(109.54)
1.00
1.00
7.75
6.71
β (SE) =
0.009 (0.011)
80 to <100
18.00
0.89 (0.39-2.18)
1.17
13.43
15.32
χ2 (df) =
0.47 (1)
<80
41.17
1.35 (0.57-3.36)
1.44
11.17
10.31
9: LANGE
FEV1%P
80+
(100.99)
1.00
1.00
47.92
48.77
β (SE) =
0.020 (0.004)
40 to <80
32.64
2.10 (1.30-3.40)
1.93
24.67
23.05
χ2 (df) =
0.17 (1)
<40
69.50
3.90 (2.20-7.20)
4.05
13.46
14.23
11: MANNIN
FEV1%P
80+
(100.24)
1.00
1.00
84.98
84.94
β (SE) =
0.022 (0.006)
<80
33.97
2.12 (1.44-3.11)
2.12
35.83
35.87
12: MRFIT
FEV1 unnormalised,ml
≥3674
(105.91)
1.00
1.00
27.01
26.50
β (SE) =
0.031 (0.005)
3307 to 3673
10.05
1.31 (0.82-2.10)
1.37
45.30
46.34
χ2 (df) =
0.85 (3)
2985 to 3306
15.92
1.50 (0.95-2.36)
1.64
54.20
58.27
 
 
2606 to 2984
22.21
2.13 (1.39-3.26)
2.00
80.62
74.45
 
 
≤2605
37.59
3.13 (2.07-4.72)
3.23
106.01
107.59
13: NOMURA
FEV1%P
103.5+
(113.14)
1.00
1.00
22.16
23.76
β (SE) =
0.018 (0.005)
94.5 to <103.5
14.40
1.00 (0.60-1.90)
1.29
23.34
32.35
χ2 (df) =
11.40 (2), p<0.01
84.5 to <94.5
23.45
2.50 (1.50-4.10)
1.52
44.66
29.09
 
 
<84.5
43.11
2.10 (1.30-3.50)
2.15
49.51
54.48
14: PETO
SDs of FEV1/h3 below average
Above average
(103.85)
1.00
1.00
32.15
39.80
β (SE) =
0.018 (0.008)
0 to 1
15.05
2.17 (1.40-3.38)
1.32
46.77
35.18
χ2 (df) =
6.81 (2), p<0.05
1 to 2
34.30
2.02 (0.97-3.90)
1.88
9.93
11.43
 
 
2+
65.85
1.89 (0.37-5.90)
3.35
2.03
4.47
15: PURDUE
FEV1%P
80+
(100.13)
1.00
1.00
1698.83
1698.83
β (SE) =
0.023 (0.002)
<80
31.76
2.06 (1.77-2.39)
2.06
189.24
189.24
16: RENFREh
FEV1%P
Quintile 5
(116.04)
1.00
1.00
31.54
35.64
β (SE) =
0.015 (0.003)
Quintile 4
13.70
1.36 (0.86-2.13)
1.22
42.34
42.97
χ2 (df) =
1.48 (3)
Quintile 3
23.79
1.81 (1.18-2.78)
1.42
55.91
49.41
 
 
Quintile 2
35.19
1.93 (1.27-2.94)
1.67
62.88
61.57
 
 
Quintile 1
57.75
2.53 (1.69-3.79)
2.32
79.83
82.90
17: RENFREi
FEV1%P
Quintile 5
(119.96)
1.00
1.00
6.22
15.69
β (SE) =
0.011 (0.005)
Quintile 4
13.53
3.63 (1.49-8.84)
1.15
21.19
16.98
χ2 (df) =
8.39 (3), p<0.05
Quintile 3
24.26
4.03 (1.68-9.67)
1.29
24.88
20.11
 
 
Quintile 2
36.19
4.12 (1.73-9.81)
1.47
27.21
24.40
 
 
Quintile 1
59.75
4.37 (1.84-10.42)
1.88
27.40
29.72
18: SKILLR
FEV1%P
85+
(100.81)
1.00
1.00
1.99
1.99
β (SE) =
0.034 (0.017)
< = 70
44.85
4.50 (0.99-20.37)
4.50
8.97
8.97
19: SPEIZEh
Mean FEV1,ℓ.j
4.07
(109.98)
1.00
1.00
2.09
3.72
β (SE) =
0.048 (0.014)
3.54
9.02
4.33 (1.19-23.71)
1.54
9.35
5.93
χ2 (df) =
4.49 (2)
3.18
16.84
2.10 (0.45-12.96)
2.25
3.85
7.35
 
 
2.55
33.30
9.60 (2.93-49.67)
4.98
21.90
20.19
20: SPEIZEi
Mean FEV1,ℓ.j
2.90
(112.16)
1.00
1.00
0.50
0.62
β (SE) =
0.054 (0.029)
2.57
10.10
3.17 (0.25-166.25)
1.73
1.36
0.92
χ2 (df) =
0.52 (2)
2.34
19.47
2.05 (0.11-121.19)
2.86
0.85
1.48
 
 
1.95
35.49
8.94 (1.20-396.75)
6.80
5.74
5.43
21: STAVEM
Mean FEV1%P
121.90
(121.90)
1.00
1.00
8.99
6.19
β (SE) =
0.021 (0.008)
106.60
15.30
0.78 (0.29-2.07)
1.38
6.89
8.42
χ2 (df) =
4.48 (2)
95.30
26.60
0.67 (0.24-1.86)
1.76
6.00
10.86
 
 
75.70
46.20
2.23 (1.03-4.83)
2.67
20.40
16.82
24: TOCKMA
FEV1%P
>85
(102.90)
1.00
1.00
22.27
22.72
β (SE) =
0.021 (0.010)
60 to 85
27.52
2.57 (0.87-7.56)
1.78
3.82
2.70
χ2 (df) =
0.60 (1)
<60
57.43
2.72 (0.76-9.74)
3.34
2.61
3.27
25: VANDENk
FEV1 unnormalised, ℓ
3.85+
(105.38)
1.00
1.00
5.34
4.12
β (SE) =
0.018 (0.013)
3.35-3.85
7.12
1.19 (0.41-3.49)
1.14
8.82
6.47
χ2 (df) =
2.23 (3)
2.85-3.35
9.72
0.76 (0.27-2.14)
1.19
10.80
13.02
 
 
2.35-2.85
11.23
0.76 (0.27-2.14)
1.22
11.01
13.64
 
 
<2.35
31.46
1.49 (0.55-4.05)
1.75
13.75
12.46
26: VANDENl
FEV1 unnormalised, ℓ
3.85+
(106.21)
1.00
1.00
6.84
10.05
β (SE) =
0.010 (0.007)
3.35-3.85
5.47
1.43 (0.60-3.42)
1.06
18.46
20.11
χ2 (df) =
1.63 (3)
2.85-3.35
10.13
1.76 (0.78-3.93)
1.11
41.81
38.92
 
 
2.35-2.85
14.67
1.80 (0.83-3.91)
1.17
81.93
78.13
 
 
<2.35
35.27
2.04 (0.92-4.54)
1.44
45.94
47.77
27: VANDENm
FEV1 unnormalised, ℓ
3.85+
(104.52)
1.00
1.00
24.68
29.86
β (SE) =
0.012 (0.003)
3.35-3.85
9.72
1.32 (0.82-2.12)
1.12
55.20
56.66
χ2 (df) =
1.69 (3)
2.85-3.35
14.29
1.43 (0.94-2.19)
1.18
141.35
140.99
 
 
2.35-2.85
21.15
1.62 (1.08-2.44)
1.28
267.93
255.94
 
 
<2.35
40.79
1.89 (1.24-2.87)
1.61
167.40
173.12
28: VANDENn
FEV1 unnormalised, ℓ
2.75+
(105.01)
1.00
1.00
7.50
5.82
β (SE) =
−0.004 (0.016)
2.35-2.75
7.32
0.76 (0.30-1.90)
0.97
11.34
11.31
χ2 (df) =
2.92 (3)
2.05-2.35
8.70
0.60 (0.27-1.34)
0.97
29.24
36.34
 
 
1.65-2.05
8.73
0.92 (0.40-2.12)
0.97
21.57
17.51
 
 
<1.65
22.96
0.76 (0.33-1.78)
0.91
18.43
17.11
29: VANDENo
FEV1 unnormalised, ℓ
2.35-2.75p
(97.83)
1.00
1.00
11.85
9.95
β (SE) =
0.026 (0.011)
2.05-2.35
3.02
1.25 (0.61-2.57)
1.08
19.20
13.93
χ2 (df) =
6.55 (2), p<0.05
1.65-2.05
5.49
0.54 (0.24-1.21)
1.15
11.29
20.27
 
 
<1.65
27.83
1.92 (0.92-4.02)
2.05
17.24
15.43
30: VANDENq
FEV1 unnormalised, ℓ
2.75+
(103.28)
1.00
1.00
9.63
21.54
β (SE) =
0.019 (0.004)
2.35-2.75
9.74
2.90 (1.46-5.77)
1.20
51.91
47.91
χ2 (df) =
8.13 (3), p<0.05
2.05-2.35
15.25
3.33 (1.72-6.48)
1.33
86.50
77.06
 
 
1.65-2.05
21.26
3.33 (1.74-6.37)
1.48
166.89
166.21
 
 
<1.65
41.80
4.76 (2.47-9.19)
2.17
107.33
109.53
31: WILES
FEV1/h3, cl/m3
56+
(105.56)
1.00
1.00
23.36
25.12
β (SE) =
0.021 (0.008)
43-56
17.66
1.69 (0.97-2.94)
1.46
25.01
23.20
χ2 (df) =
1.02 (2)
30-43
36.24
2.65 (1.29-5.20)
2.17
11.02
9.68
 
 
0-30
70.93
2.87 (0.56-9.30)
4.54
1.97
3.34
32: WILSONg
FEV1%P
80+
(100.14)
1.00
1.00
10.78
10.85
β (SE) =
0.008 (0.007)
50 to <80
30.94
1.30 (0.64-2.65)
1.28
22.87
22.73
χ2 (df) =
0.002 (1)
<50
62.07
1.65 (0.70-3.90)
1.65
9.21
9.28
TOTALr
FEV1%P
 
(106.16)
 
 
388.51
431.45
χ2 (df) =
8.43 (5)
 
0.01-10
 
 
259.67
257.83
 
 
 
10.01-20
 
 
666.20
658.51
 
 
 
20.01-30
 
 
742.1
694.76
 
 
 
30.01-40
 
 
364.31
358.07
      >40     542.36 562.52

a For each block, the block number and study reference code is shown. Also shown in columns 1 and 2 are the values of β, the fitted slope of the relationship of log RR to the estimated mean difference (see note d), and the SE of β, and also, for blocks with more than two levels, the results of the goodness-of-fit test.

b This is the measure the data were originally recorded in.

c The range of values of the measure for which results were available.

d The estimated mean difference of FEV1%P between the comparison level and the level of interest. Shown in brackets is the estimate of FEV1%P for the comparison level.

e These are pseudo-numbers of cases estimated using the method of Hamling et al.[16].

f FEV1/FVC ≥0.70.

g FEV1/FVC<0.70.

h Males.

i Females.

j RRs were given by quartiles of FEV1 residuals calculated from a prediction equation. Mean FEV1 levels for each quartile were used to derive the differences in FEV1%P.

k Male never smokers.

l Male former smokers.

m Male current smokers.

n Female never smokers.

o Female former smokers.

p There were no deaths in the highest quintile (2.75+ ℓ).

q Female current smokers.

r Total over all blocks with more than two levels.